Form 8-K - Current report:
SEC Accession No. 0000912282-17-000161
Filing Date
2017-07-25
Accepted
2017-07-25 13:18:18
Documents
3
Period of Report
2017-07-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 antriabio8k_072417.htm 8-K 18390
2 PRESS RELEASE ex99_1.htm EX-99.1 8188
3 image0.jpg GRAPHIC 7827
  Complete submission text file 0000912282-17-000161.txt   38623
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54495 | Film No.: 17980065
SIC: 2834 Pharmaceutical Preparations